These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9148475)

  • 1. [Strain tendinitis--short-term treatment with antiphlogistics. Experiences from a four-day march in Nijmegen 1996].
    Hysing J; Fretland I
    Tidsskr Nor Laegeforen; 1997 Mar; 117(8):1092-3. PubMed ID: 9148475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study.
    Mazières B; Rouanet S; Guillon Y; Scarsi C; Reiner V
    J Rheumatol; 2005 Aug; 32(8):1563-70. PubMed ID: 16078335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenosynovitis caused by texting: an emerging disease.
    Ashurst JV; Turco DA; Lieb BE
    J Am Osteopath Assoc; 2010 May; 110(5):294-6. PubMed ID: 20538752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis.
    Petri M; Hufman SL; Waser G; Cui H; Snabes MC; Verburg KM
    J Rheumatol; 2004 Aug; 31(8):1614-20. PubMed ID: 15290743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short-term treatment with naproxen].
    Finholt E
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1510-1. PubMed ID: 9198934
    [No Abstract]   [Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
    Schnitzer TJ; Kamin M; Olson WH
    Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iliotibial band Z-lengthening.
    Richards DP; Alan Barber F; Troop RL
    Arthroscopy; 2003 Mar; 19(3):326-9. PubMed ID: 12627161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fixed-dose combination of sumatriptan and naproxen for migraine.
    Med Lett Drugs Ther; 2008 Jun; 50(1288):45-6. PubMed ID: 18551089
    [No Abstract]   [Full Text] [Related]  

  • 11. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic tendon pathology: molecular basis and therapeutic implications.
    Riley G
    Expert Rev Mol Med; 2005 Mar; 7(5):1-25. PubMed ID: 15796783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
    Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
    Foeldvari I; Szer IS; Zemel LS; Lovell DJ; Giannini EH; Robbins JL; West CR; Steidle G; Krishnaswami S; Bloom BJ
    J Rheumatol; 2009 Jan; 36(1):174-82. PubMed ID: 19012356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.
    Ta LE; Dionne RA
    Pain; 2004 Sep; 111(1-2):13-21. PubMed ID: 15327804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of the non-steroidal anti-inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis.
    Wober W; Rahlfs VW; Büchl N; Grässle A; Macciocchi A
    Int J Clin Pract; 1998; 52(3):169-75. PubMed ID: 9684433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.